Synthesis of R-Amino Ketimines and Amino Aziridines
J . Org. Chem., Vol. 66, No. 8, 2001 2767
[R]22 ) -104.8 (c 1.05, CHCl3); 1H NMR (CDCl3, 300 MHz) δ
(2S)-(Z)-N,N-Diben zyl-3-(ben zylim in o)-4-ch lor o-1-ph en -
ylbu ta n -2-a m in e (2j): Rf ) 0.48 (hexane/ethyl acetate 5/1);
1H NMR (CDCl3, 300 MHz) δ 7.42-7.21 (20 H, m), 4.70 (2 H,
AB syst, J ) 16.1), 4.00 (2 H, s), 3.83 (2 × 2 H, AB syst, J )
13.6), 3.82 (1 H, dd, J ) 9.8, 3.1), 3.52 (1 H, dd, J ) 13.4, 9.8),
3.09 (1 H, dd, J ) 13.4, 3.1); 13C NMR (CDCl3, 75 MHz) δ 163.4,
139.8, 139.0, 129.1, 128.4, 127.8, 127.7, 127.2, 126.5, 126.2,
126.1, 64.5, 54.4, 53.6, 34.6, 27.9; IR (neat) 1662.
Gen er a l P r oced u r e for th e Syn th esis of Am in o Azir i-
d in es 3. Meth od A. To a -15 °C stirred solution of the
corresponding ketimine 2 (1 mmol) in THF (10 mL) was added
LiAlH4 (0.3 mL of solution 1.0 M in THF, 0.3 mmol). The
resulting solution was stirred for 1 h, at the same temperature,
and added to water. The resulting solution was filtered
through a pad of Celite, and the filtrate was extracted with
diethyl ether. The combined organic layers were dried (Na2-
SO4), filtered, and concentrated in vacuo. The amino aziridines
3 were examined by 1H NMR to give the diastereomeric excess
reported in Table 2. Flash column chromatography over silica
gel (hexane/ethyl acetate ) 15:1) provided pure compounds 3.
D
7.40-7.24 (10 H, m), 4.10 (2 H, AB syst, J ) 10.9), 3.67-3.46
(2 H, m), 3.62 (2 × 2 H, AB syst, J ) 13.5), 1.85-0.93 (10 H,
m), 1.26 (3 H, d, J ) 6.5); 13C NMR (CDCl3, 75 MHz) δ 162.8,
139.2, 128.4, 127.8, 126.5, 59.1, 57.1, 53.4, 33.5, 33.1, 32.9, 25.2,
24.6, 23.8, 7.4; IR (neat) 1660; MS, m/z 346 (M+ - HCl, <1),
224 (34), 91 (100); HRMS calcd for C24H31N2 (M - HCl)+
346.2409, found 346.2413. Anal. Calcd for C24H31ClN2: C,
75.27; H, 8.16; N, 7.31. Found: C, 75.20; H, 8.28; N, 7.39.
(2S)-(Z)-N,N-Diben zyl-3-(ben zylim in o)-4-ch lor obu ta n -
2-a m in e (2d ): Rf ) 0.31 (hexane/ethyl acetate 10/1); 1H NMR
(CDCl3, 300 MHz) δ 7.61-7.47 (15 H, m), 4.88 (2 H, AB syst,
J ) 17.3), 4.30 (2 H, AB syst, J ) 10.9), 3.89 (1H, q, J ) 6.5),
3.85 (2 × 2 H, AB syst, J ) 13.5), 1.54 (3 H, d, J ) 6.5); 13C
NMR (CDCl3, 75 MHz) δ 167.1, 139.5, 139.3, 128.6, 128.0,
127.1, 126.8, 126.3, 58.4, 54.4, 54.0, 33.8, 7.6; IR (neat) 1661;
MS m/z 354 (M+ - HCl, 2), 263 (24), 91 (100); HRMS calcd for
C
25H26N2 (M - HCl)+ 354.2096, found 354.2076.
(2S)-(Z)-N,N-Diben zyl-4-ch lor o-3-(d ip h en ylm eth ylim i-
n o)bu ta n -2-a m in e (2e): Rf ) 0.44 (hexane/ethyl acetate 5/1);
1H NMR (CDCl3, 300 MHz) δ 7.46-7.21 (20 H, m), 5.96 (1 H,
s), 4.13 (2 H, AB syst, J ) 10.9), 3.69 (1 H, q, J ) 6.7), 3.64 (2
× 2 H, AB syst, J ) 13.5), 1.41 (3 H, d, J ) 6.7); 13C NMR
(CDCl3, 75 MHz) δ 165.9, 139.5, 139.3, 128.6, 128.0, 127.1,
126.8, 126.3, 67.4, 58.0, 53.9, 34.1, 7.7; IR (neat) 1660; MS,
m/z 430 (M+ - HCl, <1), 174 (57), 167 (90), 106 (91), 91 (100);
HRMS calcd for C31H30N2 (M - HCl)+ 430.2409, found 430.2403.
Meth od B. To a stirred solution of the corresponding
ketimine 2 (1 mmol) in methanol (10 mL) was added NaBH4
(0.08 g, 2.0 mmol) at room temperature. After being stirred at
the same temperature overnight, the mixture was quenched
with a saturated aqueous solution of NH4Cl (5 mL) and
extracted with diethyl ether. The combined organic layers were
dried (Na2SO4), filtered, and concentrated in vacuo. The amino
1
aziridines 3 were examined by H NMR to give the diastere-
(-)-(3S)-(Z)-N,N-Diben zyl-2-(allylim in o)-1-ch lor o-5-m eth-
omeric excess reported in Table 2. Flash column chromatog-
raphy over silica gel (hexane/ethyl acetate ) 15:1) provided
pure compounds 3.
ylh exa n -3-a m in e (2f): Rf ) 0.41 (hexane/ethyl acetate 10/1);
[R]22 ) -105.9 (c 1.07, CHCl3); 1H NMR (CDCl3, 300 MHz) δ
D
7.38-7.27 (10 H, m), 6.00 (1 H, ddt, J ) 17.0, 10.5, 5.2), 5.22
(1 H, dq, J ) 17.0, 1.7), 5.10 (1 H, dq, J ) 10.5, 1.7), 4.23-
4.05 (2 H, m), 3.95 (2 H, AB syst, J ) 10.9), 3.64 (2 × 2 H, AB
syst, J ) 13.5), 3.50-3.40 (1 H, m), 2.18-2.09 (1 H, m), 1.59-
When the reaction was carried out at -30 °C, the procedure
was similar to that described above. After the mixture of
aziridine and chloro diamine was isolated, MeLi (0.45 mL of
solution 1.5 M in diethyl ether, 1 mmol) was added to a stirred
solution of this mixture in THF (5 mL) at -78 °C. The resulting
solution was stirred for 1 h at room temperature and quenched
with a saturated aqueous solution of NH4Cl (3 mL). Usual
workup provided the amino aziridines 3.
1.46 (2 H, m), 1.02 (3 H, d, J ) 6.5), 0.90 (3 H, d, J ) 6.5); 13
C
NMR (CDCl3, 75 MHz) δ 164.8, 139.7, 135.6, 128.8, 128.0,
126.8, 114.9, 60.3, 53.8, 53.2, 34.6, 30.2, 25.1, 23.8, 21.7; IR
(neat) 1662, 1650; MS m/z 346 (M+ - HCl, 1), 266 (47), 91
(100); HRMS calcd for C24H30N2 (M - HCl)+ 346.2409, found
346.2399. Anal. Calcd for C24H31ClN2: C, 75.27; H, 8.16; N,
7.31. Found: C, 75.09; H, 8.10; N, 7.28.
Meth od C. NaBH3CN (0.075 g, 1.2 mmol) was added to a
stirred solution of 2 (1 mmol) in methanol (10 mL) at room
temperature. After the solution was stirred overnight at the
same temperature, the solvents were removed in vacuo. The
resulting residue was dissolved in diethyl ether and washed
with brine (5 mL). Usual workup provided the amino aziridine
(3S)-(Z)-N,N-Diben zyl-2-(ben zylim in o)-1-ch lor o-5-m eth -
ylh exa n -3-a m in e (2g): Rf ) 0.42 (hexane/ethyl acetate 10/
1); 1H NMR (CDCl3, 300 MHz) δ 7.40-7.30 (15 H, m), 4.71 (2
H, AB syst, J ) 16.2), 4.06 (2 H, AB syst, J ) 10.8), 3.69-
3.44 (1 H, m), 3.68 (2 × 2 H, AB syst, J ) 13.7), 2.28-2.19 (1
H, m), 1.62-1.37 (2 H, m), 1.21 (3 H, d, J ) 6.4), 1.09 (3 H, d,
J ) 6.4); 13C NMR (CDCl3, 75 MHz) δ 164.5, 139.4, 128.5,
128.0, 127.8, 126.9, 126.2, 126.1, 60.3, 54.0, 53.6, 34.6, 30.1,
25.0, 23.6, 21.6; IR (neat) 1660; MS, m/z 396 (M+ - HCl, <1),
266 (68), 91 (100); HRMS calcd for C28H32N2 (M - HCl)+
396.2565, found 396.2566.
1
3, which was examined by H NMR and/or GC/MS to give the
diastereomeric excess reported in Table 3. Flash column
chromatography (silica gel, hexane:ethyl acetate ) 15:1)
provided pure compound 3.
(-)-(2S,1′S)-1-Allyl-2-[1′-(d ib en zyla m in o)et h yl]a zir i-
d in e (3a ): Rf ) 0.32 (hexane/ethyl acetate 5/1); [R]22D ) -20.2
1
(c 0.64, CHCl3); H NMR (CDCl3, 300 MHz) δ 7.52-7.28 (10
(-)-(2S)-(Z)-N,N-Diben zyl-4-ch lor o-3-(cycloh exylim in o)-
1-p h en ylbu ta n -2-a m in e (2h ): Rf ) 0.53 (hexane/ethyl acetate
5/1); [R]22D ) -67.3 (c 1.09, CHCl3); 1H NMR (CDCl3, 300 MHz)
δ 7.42-7.23 (15 H, m), 3.84 (2 H, AB syst, J ) 10.7), 3.72 (2
× 2 H, AB syst, J ) 13.4), 3.60 (1 H, dd, J ) 10.0, 2.8), 3.53-
3.43 (1 H, m), 3.39 (1 H, dd, J ) 12.8, 10.0), 2.94 (1 H, dd, J
) 12.8, 2.8) 1.76-1.29 (10 H, m); 13C NMR (CDCl3, 75 MHz)
δ 159.4, 140.3, 139.6, 129.6, 128.7, 128.1, 127.6, 126.8, 125.2,
63.9, 59.5, 53.6, 34.5, 33.8, 33.2, 28.0, 25.4, 24.2, 24.1; IR (neat)
1663; MS m/z 422 (M+ - HCl, 7), 331 (26), 249 (12), 91 (100);
HRMS calcd for C30H34N2 (M - HCl)+ 422.2722, found 422.2708.
Anal. Calcd for C30H35ClN2: C, 78.49; H, 7.68; N, 6.10.
Found: C, 78.17; H, 7.70; N, 6.15.
H, m), 6.06 (1 H, ddt, J ) 17.0, 10.0, 5.7), 5.29 (1 H, dd, J )
17.0, 1.7), 5.20 (1 H, dd, J ) 10.0, 1.7), 3.83 (2 × 2 H, AB syst,
J ) 13.9), 3.02 (1 H, dd, J ) 13.9, 6.1), 2.93-2.80 (2 H, m),
1.69-1.66 (2 H, m), 1.25 (1 H, d, J ) 6.5), 1.07 (3 H, d, J )
7.0); 13C NMR (CDCl3, 75 MHz) δ 140.4, 135.5, 128.3, 127.8,
126.3, 116.1, 63.4, 54.8, 53.9, 41.5, 30.1, 11.9; IR (neat) 3027,
1656; MS m/z 306 (M+, <1), 224 (24), 215 (61), 91.0 (100);
HRMS calcd for C21H26N2 306.2096, found 306.1953. Anal.
Calcd for C21H26N2: C, 82.31; H, 8.55; N, 9.14. Found: C, 82.43;
H, 8.47; N, 9.09. Chiral HPLC analysis: ee >99% (Chiralcel
OD-H, UV detector 215 nm, 0.4 mL/min, 199/1 hexane/ethanol,
tR 10.6 min).
(-)-(2S,1′S)-2-[1′-(Diben zyla m in o)eth yl]-1-p r op yla zir i-
(2S)-(Z)-N,N-Diben zyl-4-ch lor o-3-[(p-m eth oxyp h en yl)-
im in o]-1-p h en ylbu ta n -2-a m in e (2i): Rf ) 0.51 (hexane/ethyl
d in e (3b): Rf ) 0.24 (hexane/ethyl acetate 5/1); [R]22D ) -19.0
1
(c 0.48, CHCl3); H NMR (CDCl3, 300 MHz) δ 7.46-7.21 (10
1
acetate 5/1); H NMR (CDCl3, 300 MHz) δ 7.43-7.21 (15 H,
H, m), 3.77 (2 × 2 H, AB syst, J ) 13.4), 2.76 (1 H, dq, J )
7.0, 5.7), 2.30-2.15 (2 H, m), 1.66-1.53 (4 H, m), 1.15 (1 H, d,
J ) 7.0), 1.00 (3 H, d, J ) 7.0), 0.98 (3 H, t, J ) 7.4); 13C NMR
(CDCl3, 75 MHz) δ 140.3, 128.3, 127.8, 126.4, 63.1, 54.6, 53.9,
41.6, 30.4, 22.7, 11.7; IR (neat) 3028; MS m/z 308 (M+, <1),
224 (45), 217 (84), 91 (100); HRMS calcd for C21H28N2 308.2252,
found 308.2247.
m), 6.88-6.58 (4 H, m), 4.03 (1 H, dd, J ) 10.5, 3.5), 3.89 (2 ×
2H, AB syst, J ) 13.5), 3.88 (2 H, AB syst, J ) 10.5), 3.80 (3
H, s), 3.48 (1 H, dd, J ) 12.9, 10.5), 3.14 (1 H, dd, J ) 12.9,
3.5); 13C NMR (CDCl3, 75 MHz) δ 164.6, 156.0, 142.3, 139.6,
139.3, 129.4, 128.6, 128.2, 127.8, 126.9, 125.4, 120.0, 114.0,
61.4, 55.1, 53.9, 35.9, 28.5; IR (neat) 1657.